Adeline Walter, Annegret Geipel, Corinna Simonini, Brigitte Strizek, Adi Sharabi-Nov, Nadav Kugler, Ran Svirsky, Jacob Segal, Marina Mor-Shalom, Lea Valinsky, Shaden Naser, Ramzia Abu Hamed, Hamutal Meiri, Ron Maymon, Howard Cuckle
{"title":"Third trimester screening for preeclampsia in twins: comparative performance of FMF algorithm, Roche and Quidel triages.","authors":"Adeline Walter, Annegret Geipel, Corinna Simonini, Brigitte Strizek, Adi Sharabi-Nov, Nadav Kugler, Ran Svirsky, Jacob Segal, Marina Mor-Shalom, Lea Valinsky, Shaden Naser, Ramzia Abu Hamed, Hamutal Meiri, Ron Maymon, Howard Cuckle","doi":"10.1159/000546981","DOIUrl":"https://doi.org/10.1159/000546981","url":null,"abstract":"<p><strong>Introduction: </strong>We aim to compare three preeclampsia screening methods in the third trimester: a) FMF multi-marker algorithm: (b) Roche triage (sFLT-1/PlGF), on fresh and stored samples; and (c) Quidel triage (PlGF) on stored samples.</p><p><strong>Methods: </strong>Women with 2 live fetuses were enrolled at 11-13 weeks' gestation. They visited the clinic every 2-4 weeks until delivery for examination. Blood testing was conducted at 11-13 weeks' gestation, and at 20-22 and 32-34 weeks' gestations. Here we evaluated the screening characteristics in the third trimester and the detection rate (DR), false-positive rate (FPR), and positive and negative predictive values (PPV and NPV) and compared the screening efficacy based on recommended cut-offs, and area under the receiver operation characteristic curve (AUROC).</p><p><strong>Results: </strong>The analysis included 146 women with twin pregnancies, including 24 (16.4%) preeclampsia cases. Preeclampsia prediction by 3rd trimester FMF algorithm for twin pregnancies had a DR=79.2%, FPR=5.3%, PPV=76.0% and NPV=95.5%. Roche triage on fresh samples prospectively using soluble fms-like tyrosine-kinase-1 (sFLT-1) versus placental growth factor (PlGF), with a cutoff ratio >38, had a DR of 62.5% and a FPR of 22.1%, PPV and NPV of 37.5% and 90.7%, respectively. Repeated testing of Roche triage using stored samples gave similar results. Quidel triage on stored samples for high-risk (PlGF <12 pg/mL) and medium risk (PlGF 12-100 pg/mL), and the two combined into one performed with similar efficacy to Roche triage. AUROC for the FMF algorithm was 0.91 (95% CI: 0.82-0.99), P<0.0001 higher compared to Roche triage of fresh samples (0.74 (0.61-0.84)0 and stored samples (0.76 (0.65-0.86)). Quidel AUROC was 0.75 (0.64-0.86).</p><p><strong>Conclusions: </strong>In twin pregnancy, the third trimester FMF multi-marker algorithm is more effective for preeclampsia screening than Roche or Quidel triages. It is up to medical centers or professional societies to decide which preeclampsia screening method to adopt, according to local resources. This study describes the strength and limitations of each screening method.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-23"},"PeriodicalIF":1.6,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144728977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stephen P Emery, Yongjae Chun, Stephanie Greene, Nika M Hazen, Lora H Rigatti
{"title":"Successful ventriculoamniotic shunting for fetal hydrocephalus in the ovine model.","authors":"Stephen P Emery, Yongjae Chun, Stephanie Greene, Nika M Hazen, Lora H Rigatti","doi":"10.1159/000547610","DOIUrl":"https://doi.org/10.1159/000547610","url":null,"abstract":"<p><strong>Introduction: </strong>Recent technological advances in fetal medicine have led some investigators to reconsider ventriculoamniotic shunting for fetal hydrocephalus, an intervention that was attempted in the 1980s but was abandoned due to perceived lack of effect. The objective of this manuscript describes outcomes after induction of hydrocephalus followed by ventriculoamniotic shunt placement and postmortem analysis.</p><p><strong>Methods: </strong>Mixed-breed fetal sheep underwent induction of hydrocephalus by injection of BioGlue® into the cisterna magna at ~85 days gestation followed by ventriculoamniotic shunt placement at ~100 days gestation. Brains were inspected by transcranial ultrasound at the time of shunt placement and after delivery using the ventricle to hemisphere ratio (VHR). The VHR at the time of shunting was compared to the VHR at end of study. Pathologic analysis was performed on gestational age-matched normal brains, shunted brains, and unshunted hydrocephalic controls.</p><p><strong>Results: </strong>Twenty-five fetal sheep underwent induction of hydrocephalus. Two fetuses were lost immediately. Of the 23 remaining fetuses, 20 (87%) developed hydrocephalus. Five fetuses served as hydrocephalic controls. Eighteen fetuses who developed hydrocephalus were assessed for a VHR by transcranial ultrasound at the time of shunt placement. The mean VHR was 0.71. Of the 20 fetuses that developed hydrocephalus, 12 underwent shunt placement. Eight shunted fetuses were available for VHR and pathologic analysis at end of study. The mean VHR at the time of shunt placement was compared to the VHR at end of study (n=8, 0.70 vs 0.5, p=0.016). Histologically, shunted brains had better neuropreservation than unshunted hydrocephalic controls.</p><p><strong>Conclusion: </strong>Hydrocephalus was induced in 87% of fetal sheep using this model. In an ovine model, ventriculoamniotic shunting both decreased the degree of hydrocephalus sonographically and improved brain histology compared to hydrocephalic controls. These findings demonstrate proof of concept in the animal model and support ongoing research in cerebrospinal fluid diversion for fetal obstructive hydrocephalus.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-22"},"PeriodicalIF":1.6,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144728976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
May Abiad, Ryne Didier, Yinka Oyelese, Alireza A Shamshirsaz, Eyal Krispin
{"title":"Intertwin Membrane Placental Cord Insertions in a Dichorionic Diamniotic Twin Pregnancy: Case Report.","authors":"May Abiad, Ryne Didier, Yinka Oyelese, Alireza A Shamshirsaz, Eyal Krispin","doi":"10.1159/000547561","DOIUrl":"https://doi.org/10.1159/000547561","url":null,"abstract":"<p><strong>Introduction: </strong>Intertwin membrane cord insertion (IMCI) is a rare variation of velamentous cord insertion (VCI) that can be seen in dichorionic twin pregnancies. This condition exposes fetal vessels to risks such as compression and rupture, which can lead to complications including fetal growth restriction (FGR) and preterm delivery.</p><p><strong>Clinical presentation: </strong>A 30-year-old woman, gravida 1 para 0, was referred at 19+5 weeks for evaluation of a dichorionic diamniotic twin pregnancy due to an abdominal cyst in Twin A, transposition of the great arteries in Twin B, and suspected abnormal cord insertions. Diagnosis & Management: Ultrasound evaluation confirmed IMCI, with both umbilical cords inserting into the intertwin membrane before reaching the placenta. MRI corroborated the findings. Doppler studies remained normal until 34+2 weeks, when signs of severe FGR and abnormal umbilical artery Dopplers prompted delivery by cesarean section. The twins were delivered preterm, and postnatal evaluation confirmed VCI.</p><p><strong>Conclusion: </strong>This case highlights the importance of early identification of IMCI, as it necessitates close monitoring and timely intervention to optimize perinatal outcomes.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-10"},"PeriodicalIF":1.6,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144689627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sierra Land, Sabrina Flohr, Leny Mathew, Anne M Ades, Beverly G Coleman, Juliana S Gebb, Julie S Moldenhauer, Olivia Nelson, Edward R Oliver, Emily A Partridge, William H Peranteau, Thomas A Reynolds, Natalie E Rintoul, Kha Tran, K Taylor Wild, Holly L Hedrick
{"title":"Fetoscopic Endoluminal Tracheal Occlusion (FETO) versus Expectant Management for Severe Congenital Diaphragmatic Hernia at a Single Center.","authors":"Sierra Land, Sabrina Flohr, Leny Mathew, Anne M Ades, Beverly G Coleman, Juliana S Gebb, Julie S Moldenhauer, Olivia Nelson, Edward R Oliver, Emily A Partridge, William H Peranteau, Thomas A Reynolds, Natalie E Rintoul, Kha Tran, K Taylor Wild, Holly L Hedrick","doi":"10.1159/000546160","DOIUrl":"https://doi.org/10.1159/000546160","url":null,"abstract":"<p><strong>Introduction: </strong>The TOTAL trial showed survival benefit in patients with severe congenital diaphragmatic hernia (CDH) who underwent fetoscopic endoluminal tracheal occlusion (FETO). We aim to add to the current literature by describing implementation, feasibility, and outcomes of patients treated with FETO compared to a contemporary cohort of expectantly managed maternal-child dyads.</p><p><strong>Methods: </strong>A single center, retrospective cohort study evaluated patients with a prenatal diagnosis of isolated left CDH with an observed/expected lung to head ratio < 30% referred to our center from September 2016 through January 2023.</p><p><strong>Results: </strong>Twelve patients who underwent FETO were compared to 35 expectantly managed patients. At initial evaluation, FETO patients had a lower O/E LHR value (21.7% versus 24.9%) compared to the expectant management patients. Chorioamniotic membrane separation occurred in half of the FETO patients (6/12) compared with one patient in the expectant management group and most FETO patients (75.0%) experienced preterm prelabor rupture of membranes (PPROM) compared to only 4 (11.4%) expectant management patients. FETO patients had a lower median gestational age at delivery compared to expectant management patients (35.0 vs 38.9 weeks). Fewer FETO patients were treated with ECMO (25.0% vs 60.0% expectant management). FETO patients also had higher survival (91.7% vs 71.4%) and longer duration of hospitalization (135 vs 94.8 days). At time of discharge, no FETO patients required pulmonary hypertension (PH) medications while 28.0% of expectant management patients were on PH medications.</p><p><strong>Conclusion: </strong>FETO for severe CDH was feasible in our single center setting. FETO may increase risk of obstetric complications and prematurity, but improved ECMO use, pulmonary hypertension, and survival of infants with severe CDH.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-17"},"PeriodicalIF":1.6,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144575146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Enhanced Recovery After Fetal Sequencing: A Perinatal Genomic Scoping Review of Exome / Genome Testing for Reproductive / Obstetric-MFM Providers to initiate Knowledge Translation following a Screening Ultrasound Identifying Fetal Anomalies.","authors":"Robert Douglas Wilson","doi":"10.1159/000546993","DOIUrl":"https://doi.org/10.1159/000546993","url":null,"abstract":"<p><strong>Introduction: </strong>This review of genomic perinatal opportunities and uses will provide counselling and personal genetic knowledge for improved patient care. M/M: This focused systematic analysis and review has used PUBMED keywords to identify genomic testing for ultrasound identified fetal anomaly (ies) that require diagnostic testing after an informed consent process.</p><p><strong>Results: </strong>Multiple fetal anomalies, using TRIO sequencing processes, have a better diagnostic yield, with certain cohorts > 50%. For the single anatomic categories, skeletal, central nervous system, and renal systems, using WES fetal sequencing (most commonly) for a diagnostic result, have the larger incremental diagnostic yield over CMA.</p><p><strong>Conclusion: </strong>The phenotype-genotype (fetal-genomic result) consideration and use of the pES technology can be summarized using a SWOT analysis: strength (enhanced evaluation of fetal-neonatal genomic abnormalities not identified by standard chromosomal microarray and improved ethical care decisions); weakness (the understanding and complexity of genomic pathology and testing / the fiscal cost for professional time and the health system services); opportunity (an increased recognition of fetal genetic risk pathology [de novo or inherited carrier mutations] with improved understanding and knowledge translation of counselling for recurrence risk); threat (inability to provide a genetic diagnosis or interpret a variant of unknown significance or the discovery of incidental findings or unanticipated parental genomic diagnoses).</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-20"},"PeriodicalIF":1.6,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144483690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Selena A Shirkin, Mariah N Snelson, Eric D McAlexander, Ayeeshi Poosarla, Gloria Kalnitskaya, Alice S Yu, Elizabeth Logsdon, Denise Wolfson, Jena L Miller, Mara Rosner, Michelle L Kush, Ahmet A Baschat
{"title":"Fetoscopic Observation of Intrauterine Operative Port Placements during Laparotomy-Assisted Fetal Myelomeningocele Closure.","authors":"Selena A Shirkin, Mariah N Snelson, Eric D McAlexander, Ayeeshi Poosarla, Gloria Kalnitskaya, Alice S Yu, Elizabeth Logsdon, Denise Wolfson, Jena L Miller, Mara Rosner, Michelle L Kush, Ahmet A Baschat","doi":"10.1159/000546666","DOIUrl":"10.1159/000546666","url":null,"abstract":"<p><strong>Introduction: </strong>Amniotic membrane disruption during laparotomy-assisted fetoscopic myelomeningocele closure port insertion is a precursor to iatrogenic preterm prelabor rupture of membranes (iPPROM), the primary contributor to obstetric complications. We hypothesized that visualization of port insertion from the intrauterine perspective could offer insight into mechanisms affecting chorioamniotic integrity.</p><p><strong>Methods: </strong>Fetoscopically video-recorded uterine port insertions during myelomeningocele closure were independently reviewed by six observers for suture placement, associated chorioamniotic separation of the membrane (referred to as tenting), and bleeding at port insertion. Findings were analyzed for interobserver agreement and related to iPPROM and gestational age at delivery.</p><p><strong>Results: </strong>In 23 surgical videos, average interobserver agreement was 78% for membrane tenting, myometrial bleeding, visible debris on the port, and the number of suture placements as distinct mechanical factors. Tenting occurred at 30.4% of suture and 30.4% of trocar insertions. Port step occurred in 100.0% of insertions, and port debris occurred in 60.9% of insertions. Bleeding occurred in 8.7% of port, and 21.7% of suture insertions. Amniotic membrane plication used 2 stitches in 65.2% of cases. iPPROM occurred in 47.8% of cases. The average gestational age at the time of surgery was 24 weeks and 4 days and, at the time of delivery, was 35 weeks and 3 days.</p><p><strong>Conclusions: </strong>Fetoscopic port insertions produce identifiable chorioamniotic disruption without any specific precursors to membrane rupture. The number, rather than the type of membrane punctures, may be more relevant for iPPROM risk.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-8"},"PeriodicalIF":1.6,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144483739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aaron W Roberts, Margaret Clement, Suzanne Marie Lopez, Rita Swinford, Percy Pacora Portella, Edgar Hernandez-Andrade, Matthew Rysavy, Anthony Johnson
{"title":"New Anhydramnios after 22 Weeks and Pulmonary Hypoplasia.","authors":"Aaron W Roberts, Margaret Clement, Suzanne Marie Lopez, Rita Swinford, Percy Pacora Portella, Edgar Hernandez-Andrade, Matthew Rysavy, Anthony Johnson","doi":"10.1159/000546988","DOIUrl":"10.1159/000546988","url":null,"abstract":"<p><strong>Introduction: </strong>Anhydramnios due to renal failure prior to 22 weeks of gestational age (WGA) is associated with lethal pulmonary hypoplasia but after 22 WGA outcomes are less clear. We evaluated whether these fetuses, with new anhydramnios after 22 WGA, incur significant risk of severe neonatal pulmonary morbidity.</p><p><strong>Methods: </strong>This retrospective study of singleton pregnancies diagnosed with new-onset renal anhydramnios after 22 WGA following verifiable normal AFI on ultrasound before 22 WGA from 2021 to 2023. Cases with bilateral renal agenesis, premature rupture of membranes, and nonrenal malformations were excluded.</p><p><strong>Results: </strong>During the study period 53,698 s trimester ultrasound examinations were performed, of which 82 patients had new anhydramnios after 22 weeks, and 6 met criteria for inclusion in the study. Renal anhydramnios in each was secondary to a lower urinary tract outlet obstruction. Two of these (2/6, 33%) underwent procedures that corrected anhydramnios and survived, the rest suffered lethal pulmonary hypoplasia.</p><p><strong>Conclusion: </strong>Onset of, and persistent, renal anhydramnios after 22 WGA is associated with lethal pulmonary morbidity. Although clinical trials to date have focused on intervention for patients with renal anhydramnios prior to 22 WGA, investigation of treatments those with renal anhydramnios after 22 WGA is warranted to mitigate severe pulmonary hypoplasia.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-7"},"PeriodicalIF":1.6,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12306945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144474406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Potential of Fetal Electrocardiography Monitoring in Evaluating Treatment Indications for Fetal Supraventricular Tachycardia.","authors":"Takeshi Ikegawa, Yuki Okada, Yuki Kamihara, Michi Kasai, Hiromi Nagase, Hiroshi Ishikawa, Hideaki Ueda, Yoshitaka Kimura, Motoyoshi Kawataki","doi":"10.1159/000547011","DOIUrl":"10.1159/000547011","url":null,"abstract":"<p><strong>Introduction: </strong>Accurate assessment of fetal supraventricular tachycardia (SVT) frequency is critical for deciding treatment strategies. In this study, we evaluated the potential of prolonged non-invasive fetal electrocardiography (fECG) monitoring for assessing SVT and guiding therapy.</p><p><strong>Case presentation: </strong>A 37-year-old woman at 28 weeks of gestation was referred to our hospital for fetal tachycardia. The patient was diagnosed with fetal arrhythmia, including occasional premature atrial contractions and SVT. Fetal heart rate monitoring using Doppler-based cardiotocography (CTG) with external transducers was insufficient for accurate frequency evaluation; moreover, brief fetal echocardiography was inadequate due to marked diurnal variation in SVT frequency. Prolonged fECG monitoring at 29 and 31 weeks of gestation revealed that SVT did not persist for 12 or more hours or for more than 50% of the monitoring period, indicating a low risk for fetal hydrops. The pregnancy proceeded normally, and the infant was born healthy at 38 weeks.</p><p><strong>Conclusion: </strong>This report suggests that prolonged fECG monitoring is a more reliable and less invasive method for assessing fetal SVT frequency compared with traditional CTG or fetal echocardiography. Furthermore, it provides a non-invasive and accurate approach for evaluating the need for fetal therapy, especially in arrhythmia cases where frequency assessment is essential.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-7"},"PeriodicalIF":1.6,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144324902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shelly Soni, Shaunessy Sneller, Susan Spinner, Julie S Moldenhauer
{"title":"Development of a Postpartum Follow-Up Program in a Fetal Center.","authors":"Shelly Soni, Shaunessy Sneller, Susan Spinner, Julie S Moldenhauer","doi":"10.1159/000547010","DOIUrl":"10.1159/000547010","url":null,"abstract":"<p><strong>Introduction: </strong>Patients delivering in a highly specialized fetal center often travel a distance from their homes and primary care providers, leaving the potential for significant gaps in comprehensive postpartum care. The objective of the study was to evaluate the implementation, engagement, and outcomes of a nurse-led postpartum follow-up program during its first year of inception.</p><p><strong>Methods: </strong>A registered nurse conducted outreach via phone, text, or email at 2-3 and 6-8 weeks postpartum for all patients who delivered in a special delivery unit of a children's hospital. Standardized scripts included medical and mental health concerns to assess engagement, postpartum complications, care utilization, contraception use, lactation, and follow-up completion.</p><p><strong>Results: </strong>Of 407 patients, 503 total outreach calls were completed. The engagement rate was high, with contact established for 89.9% of participants. At least one clinical concern was identified in over 25% of patients, prompting further follow-up. Only 1.7% required readmission and 94.3% visited an emergency department, rates comparable to national postpartum benchmarks. At 6-8 weeks, 75% had attended or scheduled a postpartum visit. Contraception use was reported by 65% of patients, and 67% reported active lactation. Mental health screening flagged 6.4% of patients, with a significantly higher rate (26.5%) among those who experienced fetal or neonatal loss compared to those who did not (4.3%, p < 0.00001).</p><p><strong>Conclusion: </strong>The implementation of a comprehensive nurse-led postpartum program in a fetal therapy center achieved a high engagement rate and demonstrated feasibility and value in bridging care gaps supporting the expansion of telehealth-based postpartum follow-up in fetal therapy centers.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-6"},"PeriodicalIF":1.6,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144324899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Left and Right Ventricular Strain Mechanics in Fetal Tachyarrhythmia.","authors":"Rukmini Komarlu, Janelle Noel-MacDonnell, Neha Chellu, Geetha Haligheri","doi":"10.1159/000546991","DOIUrl":"10.1159/000546991","url":null,"abstract":"<p><strong>Introduction: </strong>Assessment of myocardial function in fetuses with supraventricular tachyarrhythmia is challenging. Speckle-tracking echocardiography (STE) is a newer sensitive method to assess ventricular systolic function. We sought to assess left (LV) and right (RV) ventricular myocardial strain mechanics in fetuses with tachyarrhythmia and hypothesized that strain mechanics are impaired in this patient population even after conversion to sinus rhythm.</p><p><strong>Methods: </strong>This was a single-center retrospective review. LV and RV strain parameters were assessed using STE in tachyarrhythmia and after conversion to sinus rhythm and, compared to gestational age (GA), matched control fetuses in sinus rhythm.</p><p><strong>Results: </strong>Eighteen fetuses with tachyarrhythmia and 18 controls were analyzed at median GA of 31 weeks (range 28-34 weeks). LV Global Longitudinal Strain (GLS) (-4.5% [-5.2, -1.9] vs. -11.2% [-14.6, -9.9]; p value 0.0001), Strain Rate (-0.8% [-1.5, -0.6] vs. -1.7% [-2.5, -1.2]; p value 0.007), and Global Longitudinal Velocity (GLV) (0.7 cm/s [0.5, 1.3] vs. 1.8 cm/s [0.9, 2.1]; p value 0.003) were reduced in tachyarrhythmia and improved with sinus rhythm but remained abnormal compared to controls. RV GLS (-6.3% [-8.5, -5.1] vs. -13.6% [-15.3, -10.6]; p value <0.0001), Strain rate (-1.3% [-1.7, -0.9] vs. -2.1% [-2.5, -1.4]; p value 0.0103), and GLV (1.2 cm/s [0.8, 1.7] vs. 1.9 cm/s [1.2, 2.7]; p value 0.026) were low in tachyarrhythmia and improved with sinus rhythm but remained lower than in controls. Regional strain was decreased in all LV and RV segments in tachyarrhythmia.</p><p><strong>Conclusion: </strong>Fetuses in tachyarrhythmia had reduced measures of myocardial deformation that improved with sinus rhythm but remained low compared to matched controls. Future studies are needed to explore the utility of STE for serial monitoring of fetuses in tachyarrhythmia and to assess response to therapy.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-11"},"PeriodicalIF":1.6,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12286586/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144324901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}